Pharma & Biotech
Director Interviews
Pharma & Biotech
Director Interviews
Lexaria Bioscience seeing increased demand for its DehydraTECH drug delivery system
DehydraTECH masks unwanted taste, improves onset speed and increases bioavailability of active...
The bioscience company and its exclusive diagnostic partner, 3a-Diagnostics GmbH, are developing...
InnoCan is developing a revolutionary injectable CBD delivery system that facilitates targeted,...
The company plans a Phase 2 study of FSD201 in more than 300 COVID-19 patients in October this year
The company’s lead drug otenaproxesul, formerly known as ATB-346, could be a home run if it...
CytoDyn (OTCQB: CYDY) CEO Nader Pourhassan joined Steve Darling from Proactive to provide an update on how and when they expect to have approval for Leronlimab for Covid treatment. Pourhassan also told Proactive about what the recent decision by the FDA to approve Remdesivir as a...
Market Report
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
